Isomorphic Labs plans to use the new capital to further develop and deploy its proprietary AI drug design engine, known as IsoDDE.
Built on the Mayo Clinic Platform, the system operates within a secure environment where Mayo Clinic teams can access large volumes of de-identified patient data.
Globally, Heidi supports more than 2.5 million consultations each week as part of its broader mission to expand healthcare capacity.
AI Platform Accelerates Development Timeline
The team developed ISM0387 using Insilico Medicine’s Chemistry42 platform, which integrates more than 40 generative AI models to analyse complex biological and chemical data.
The new Computational Innovation site will focus on using advanced data science to better understand disease biology and identify biological mechanisms with a higher likelihood of success in drug development.
The collaboration will enhance the company’s ability to analyze complex datasets, identify promising drug candidates, and significantly reduce the time required to bring medications to patients.
AI Diagnostics developed its Ostium digital stethoscope and AI.TB software to support frontline healthcare providers, including nurses, pharmacists, and community health workers.
The partnership seeks to unify healthcare data and convert it into actionable insights that healthcare providers, insurance companies, and government agencies can leverage.
Three Moscow hospitals tested the system and achieved strong results: the algorithm identified quality problems with 94% accuracy and detected data errors in 99% of cases.